This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
I'm LongbridgeAI, I can summarize articles.Top Wall Street analysts initiated coverage on several stocks with bullish outlooks. Evercore ISI rated EROC Outperform ($28 target), JP Morgan rated WSE Overweight ($17.50 target), Goldman Sachs rated FRBT Buy ($23.50 target), B of A rated PBLS Buy ($45 target), and Stifel rated WHK Buy ($30 target). These initiations highlight positive analyst sentiment for Monday's trading.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Evercore ISI Group analyst Nicholas Amicucci initiated coverage on ERock (NYSE:EROC) with an Outperform rating and announced a price target of $28. ERock shares closed at $15.47 on Thursday. See how other analysts view this stock.
- JP Morgan analyst Craig McDowell initiated coverage on Wise Group PLC (NASDAQ:WSE) with an Overweight rating and announced a price target of $17.5. Wise Group shares closed at $12.95 on Thursday. See how other analysts view this stock.
- Goldman Sachs analyst Sahar Islam initiated coverage on Forbright (NASDAQ:FRBT) with a Buy rating and announced a price target of $23.5. Forbright shares closed at $18.75 on Thursday. See how other analysts view this stock.
- B of A Securities analyst Tazeen Ahmad initiated coverage on Parabilis Medicines (NASDAQ:PBLS) with a Buy rating and announced a price target of $45. Parabilis Medicines shares closed at $29.58 on Thursday. See how other analysts view this stock.
- Stifel analyst Selman Akyol initiated coverage on Whitehawk Minerals Corp (NYSE:WHK) with a Buy rating and announced a price target of $30. WhiteHawk Minerals shares closed at $27.37 on Thursday. See how other analysts view this stock.
Considering buying PBLS stock? Here’s what analysts think:
Photo via Shutterstock